You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Argentina Patent: 113760


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 113760

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Oct 10, 2038 Eli Lilly And Co RETEVMO selpercatinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR113760

Last updated: July 29, 2025


Introduction

Argentina Patent AR113760 pertains to a medicinal invention within the pharmaceutical sector. This patent's scope, claims, and overall patent landscape are critical for understanding its legal protections, commercial potential, and positioning within the broader pharmaceutical patent ecosystem. This analysis provides a comprehensive evaluation, focusing on the specific claims, their breadth, and the strategic landscape for similar and competing innovations.


Patent Overview and Context

Patent AR113760 was granted by the National Institute of Industrial Property (INPI) of Argentina. Its issuance aligns with Argentina’s adherence to the TRIPS Agreement, ensuring patent rights similar to those in other jurisdictions. The patent's core is centered on an innovative compound, formulation, or therapeutic method, providing exclusivity rights to the patent owner in the Argentine market.

Understanding the scope entails evaluating how broad or narrow the claims are, influencing the patent’s enforceability and its capacity to prevent infringement. The patent landscape encompasses other national and international filings, force majeure patents, and prior art that contextualizes AR113760's novelty and inventive step.


Scope of the Patent

1. Patent Classification and Technological Field

AR113760 falls within the International Patent Classification (IPC) classes related to pharmaceuticals, typically under A61K (preparations for medical, dental, or toilet purposes) and possibly C07D (heterocyclic compounds). The precise classification informs us about the invention's technical domain.

2. Claim Structure and Breadth

The claims define the legal scope, directly impacting the scope of protection:

  • Independent Claims: Likely centered on the compound's chemical structure, a novel pharmaceutical formulation, or a unique method of treatment.
  • Dependent Claims: Usually elaborate on preferred embodiments, specific substituents, dosages, or administration methods.

The breadth of claims determines enforceability:

  • Narrow Claims: Focused on a specific compound or method, easier to invalidate but provide limited protection.
  • Broad Claims: Cover entire classes of compounds or methods, offering extensive protection but risked being challenged for lack of inventive step or novelty.

3. Composition of Matter vs. Method Claims

The patent may encompass:

  • Composition of Matter Claims: Covering the chemical compound or pharmaceutical formulation.
  • Method of Use Claims: Protecting therapeutic methods, including indications and dosages.

In Argentina, the scope's strength depends on how well the claims are drafted to balance breadth and defensibility.


Claims Analysis

1. Structural and Chemical Claims

If AR113760 claims a specific chemical entity, it likely includes several embodiments with slight modifications, such as salts, stereoisomers, or derivatives. Validity hinges on demonstrating novelty over prior art, inventive step, and sufficient disclosure.

2. Formulation and Delivery Claims

Claims may encompass formulations with unique excipients or delivery mechanisms (e.g., controlled-release systems). Such claims expand the patent's protective umbrella beyond the core compound.

3. Therapeutic Method Claims

Method claims for treating specific conditions, such as cancer or infectious diseases, potentially provide supplementary protection, especially if written broadly (e.g., "a method for treating [disease] comprising administering an effective amount of the compound").

4. Limitations and Narrowing Factors

The presence of narrow dependent claims or disclaimers may impact enforceability. Claims that rely on specific properties or parameters (e.g., dissolution rate, bioavailability) are more restrictive.


Patent Landscape in Argentina

1. Prior Art and Patentability

Key considerations involve:

  • Novelty: The invention must be new in Argentina, not disclosed publicly before the filing date.
  • Inventive Step: The invention must involve an inventive activity beyond existing knowledge.
  • Industrial Applicability: The invention must be capable of some industrial application.

AR113760’s patentability likely relied on demonstrating these aspects vis-à-vis prior art, including international filings, academic publications, and existing patents.

2. Comparative Landscape

Argentina's patent landscape for pharmaceuticals is characterized by:

  • A sizable number of patents filed through local applicants and foreign corporations.
  • Notable filings in similar classes, targeting disease-specific treatments, formulations, or chemical structures.

AR113760's scope's strength can be compared with local and international patents lexicon, especially from patent families associated with the same inventor or assignee.

3. Patent Families and International Prosecution

If the applicant pursued PCT filings, AR113760 may be part of a broader international patent family protecting the same invention in multiple jurisdictions, affecting its strategic value.

4. Challenges and Enforcement

In Argentina, patent validity can be challenged via nullity actions or oppositions. The breadth of claims heightens the importance of clear patent prosecution and specification to withstand legal scrutiny.


Legal and Commercial Implications

1. Market Exclusivity

AR113760 grants exclusive rights in Argentina for the duration of the patent (generally 20 years from filing), subject to maintenance fees. This exclusivity allows patentees to maximize return on investment and potentially license or sublicense the active pharmaceutical ingredient (API).

2. Competitive Landscape

The scope of the patent influences competitors' strategies:

  • Designing around the invention if claims are narrow.
  • Challenging validity if claims are overly broad or unsupported.

3. Licensing and Strategic Partnerships

Broader claims might facilitate licensing deals, especially if the invention covers a wide chemical class or therapeutic application.


Concluding Remarks

Benchmarking AR113760’s claims and scope reveals a strategic patent likely characterized by a balance between breadth for market protection and specificity for validity. Its position within the Argentine patent landscape is reinforced by local innovation, possibly coupled with international patent family filings.

A holistic approach to prosecution, robust claim drafting, and thorough prior art searches underpin the patent's strength against invalidation or infringement challenges. The pharmaceutical landscape in Argentina remains dynamic, with patent rights like AR113760 playing a crucial role in fostering innovation and commercialization exclusivity.


Key Takeaways

  • Claim Breadth is Critical: Narrow claims protect specific formulations but offer limited coverage; broad claims increase enforceability risks but maximize protection.
  • Patent Landscape Context: AR113760 exists within a competitive, innovation-driven environment with international patent family considerations.
  • Legal Robustness: Adequate specification and clear claim language are essential for patent validity in Argentina.
  • Commercial Strategy: Patent scope influences licensing, enforcement, and market exclusivity strategies.
  • Continuous Monitoring: Regular review of local and international patent statuses is necessary to sustain competitive advantage.

FAQs

1. What factors determine the strength of the claims in AR113760?
The claim strength depends on their clarity, breadth, novelty, inventive step, and support in the detailed description. Broad, well-supported claims tend to be more robust.

2. Can competitors legally develop similar drugs around AR113760?
Potentially, if they design around the claims or if the patent is successfully challenged on validity grounds, they may develop similar compounds or treatments.

3. How does the patent landscape in Argentina influence AR113760’s enforceability?
The presence of prior art, similar patents, or opposition proceedings can affect enforceability. A rigorous patent prosecution enhances enforceability.

4. Does Argentina’s patent law allow for patent term extensions?
Generally, patents are granted for 20 years from application filing. Argentina does not currently implement patent term extensions for pharmaceutical patents.

5. How important is international patent protection for pharmaceuticals like AR113760?
International protection is critical for global market access, licensing, and safeguarding investment, especially through PCT filings and regional applications.


References
[1] Argentine Patent Law and Regulations, INPI Argentina
[2] World Intellectual Property Organization (WIPO), Patent Cooperation Treaty (PCT) filings and proceedings
[3] INPI Patent Database and Publication Details for AR113760

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.